Literature DB >> 20054123

Preliminary crystallographic analysis of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA.

Vinod B Agarkar1, Nigar D Babayeva, Angie Rizzino, Tahir H Tahirov.   

Abstract

Ets proteins are transcription factors that activate or repress the expression of genes that are involved in various biological processes, including cellular proliferation, differentiation, development, transformation and apoptosis. Like other Ets-family members, Elf3 functions as a sequence-specific DNA-binding transcriptional factor. A mouse Elf3 C-terminal fragment (amino-acid residues 269-371) containing the DNA-binding domain has been crystallized in complex with mouse type II TGF-beta receptor promoter (TbetaR-II) DNA. The crystals belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 42.66, b = 52, c = 99.78 A, and diffracted to a resolution of 2.2 A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20054123      PMCID: PMC2802875          DOI: 10.1107/S1744309109038007

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.

Authors:  J A Nye; J M Petersen; C V Gunther; M D Jonsen; B J Graves
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

Review 2.  Ets transcription factors and human disease.

Authors:  J Dittmer; A Nordheim
Journal:  Biochim Biophys Acta       Date:  1998-04-17

3.  Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.

Authors:  J Chang; C Lee; K B Hahm; Y Yi; S G Choi; S J Kim
Journal:  Oncogene       Date:  2000-01-06       Impact factor: 9.867

4.  Different domains of the transcription factor ELF3 are required in a promoter-specific manner and multiple domains control its binding to DNA.

Authors:  Janel L Kopp; Phillip J Wilder; Michelle Desler; Leo Kinarsky; Angie Rizzino
Journal:  J Biol Chem       Date:  2006-12-05       Impact factor: 5.157

Review 5.  The Ets family of transcription factors.

Authors:  B Wasylyk; S L Hahn; A Giovane
Journal:  Eur J Biochem       Date:  1993-01-15

6.  Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.

Authors:  L W Donaldson; J M Petersen; B J Graves; L P McIntosh
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

7.  A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor.

Authors:  S G Choi; Y Yi; Y S Kim; M Kato; J Chang; H W Chung; K B Hahm; H K Yang; H H Rhee; Y J Bang; S J Kim
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

8.  A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer.

Authors:  M J Tymms; A Y Ng; R S Thomas; B C Schutte; J Zhou; H J Eyre; G R Sutherland; A Seth; M Rosenberg; T Papas; C Debouck; I Kola
Journal:  Oncogene       Date:  1997-11-13       Impact factor: 9.867

9.  ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.

Authors:  C H Chang; G K Scott; W L Kuo; X Xiong; Y Suzdaltseva; J W Park; P Sayre; K Erny; C Collins; J W Gray; C C Benz
Journal:  Oncogene       Date:  1997-04-03       Impact factor: 9.867

Review 10.  ETS transcription factors and regulation of immunity.

Authors:  Sarah Gallant; Gary Gilkeson
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2006-05-02       Impact factor: 4.291

View more
  1 in total

1.  Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA.

Authors:  Vinod B Agarkar; Nigar D Babayeva; Phillip J Wilder; Angie Rizzino; Tahir H Tahirov
Journal:  J Mol Biol       Date:  2010-01-15       Impact factor: 5.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.